Exact Mass: 431.184497

Exact Mass Matches: 431.184497

Found 138 metabolites which its exact mass value is equals to given mass value 431.184497, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Glenvastatin

Glenvastin; HR 780

C27H26FNO3 (431.18966180000007)


D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D004791 - Enzyme Inhibitors > D019161 - Hydroxymethylglutaryl-CoA Reductase Inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent C471 - Enzyme Inhibitor > C1655 - HMG-CoA Reductase Inhibitor D009676 - Noxae > D000963 - Antimetabolites

   

DTXSID10996162

3beta-Chloro-N,N-bis(2-chloroethyl)-androst-5-en-17beta-amine

C23H36Cl3N (431.19131860000005)


   

Fusarin C

Methyl (2Z,5Z,7E,9E)-11-[2,4-dihydroxy-4-(2-hydroxyethyl)-6-oxa-3-azabicyclo[3.1.0]hex-2-en-1-yl]-2-ethylidene-4,6,10-trimethyl-11-oxoundeca-3,5,7,9-tetraenoic acid

C23H29NO7 (431.1943924)


Fusarin C is produced by many Fusarium species in infected corn. Production by many Fusarium subspecies in infected corn. D009676 - Noxae > D009153 - Mutagens

   

Lafutidine

2-[(furan-2-yl)methanesulfinyl]-N-[(2Z)-4-({4-[(piperidin-1-yl)methyl]pyridin-2-yl}oxy)but-2-en-1-yl]acetamide

C22H29N3O4S (431.1878674000001)


Lafutidine is a histamine H2-receptor antagonist that inhibits histamine-stimulated gastric acid secretion. Due to the resulting reduction in gastric volume and acidity, lafutidine can be used to treat ulcers and reflux. A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BA - H2-receptor antagonists C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Lafutidine (FRG-8813) is a histamine H2-receptor antagonist (H2RA), with proven gastric mucosal protective effects. Lafutidine can be used for the research of gastroesophageal reflux disease[1].

   
   
   

Oxyprotostemonine

Oxyprotostemonine

C23H29NO7 (431.1943924)


A natural product found in Stemona kerrii and Stemona curtisii.

   

9a-O-Methylstemoenonine

(-)-9a-O-Methylstemoenonine

C23H29NO7 (431.1943924)


   
   

(3S,11R,11aR)-3-Methoxy-4,9-dimethyl-8beta-hydroxy-3beta-[[(2S,4S)-4-methyl-5-oxotetrahydrofuran]-2-yl]-2,3,5,6,7,8-hexahydrospiro[1H-cyclopenta[b]pyrrolo[1,2-a]azepine-11(10H),2(5H)-furan]-5,10-dione

(3S,11R,11aR)-3-Methoxy-4,9-dimethyl-8beta-hydroxy-3beta-[[(2S,4S)-4-methyl-5-oxotetrahydrofuran]-2-yl]-2,3,5,6,7,8-hexahydrospiro[1H-cyclopenta[b]pyrrolo[1,2-a]azepine-11(10H),2(5H)-furan]-5,10-dione

C23H29NO7 (431.1943924)


   
   

Fischerin|NFA Toxin

Fischerin|NFA Toxin

C23H29NO7 (431.1943924)


   

4-methoxy-3-methyl-5-[(2Z,3aR)-3ac,10c-epoxy-1t-methyl-8t-((2S)-4c-methyl-5-oxo-tetrahydrofuran-2r-yl)-(3ar,10at,10bt)-decahydro-2H-furo[3,2-c]pyrrolo[1,2-a]azepin-2-ylidene]-5H-furan-2-one|oxyprotostemonine

4-methoxy-3-methyl-5-[(2Z,3aR)-3ac,10c-epoxy-1t-methyl-8t-((2S)-4c-methyl-5-oxo-tetrahydrofuran-2r-yl)-(3ar,10at,10bt)-decahydro-2H-furo[3,2-c]pyrrolo[1,2-a]azepin-2-ylidene]-5H-furan-2-one|oxyprotostemonine

C23H29NO7 (431.1943924)


   
   
   
   
   
   
   
   

Lafutidine

Lafutidine

C22H29N3O4S (431.1878674000001)


A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BA - H2-receptor antagonists C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Lafutidine (FRG-8813) is a histamine H2-receptor antagonist (H2RA), with proven gastric mucosal protective effects. Lafutidine can be used for the research of gastroesophageal reflux disease[1].

   

Ala Met Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-(methylsulfanyl)butanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6S (431.18384540000005)


   

Ala Met Pro Asn

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C17H29N5O6S (431.18384540000005)


   

Ala Asn Met Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6S (431.18384540000005)


   

Ala Asn Asn Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]-3-carbamoylpropanoic acid

C15H25N7O8 (431.176453)


   

Ala Asn Pro Met

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanoic acid

C17H29N5O6S (431.18384540000005)


   

Ala Pro Met Asn

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanamido]-3-carbamoylpropanoic acid

C17H29N5O6S (431.18384540000005)


   

Ala Pro Asn Met

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-4-(methylsulfanyl)butanoic acid

C17H29N5O6S (431.18384540000005)


   

Cys Asn Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C17H29N5O6S (431.18384540000005)


   

Cys Asn Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6S (431.18384540000005)


   

Cys Pro Asn Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-methylbutanoic acid

C17H29N5O6S (431.18384540000005)


   

Cys Pro Val Asn

(2S)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-carbamoylpropanoic acid

C17H29N5O6S (431.18384540000005)


   

Cys Val Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylbutanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6S (431.18384540000005)


   

Cys Val Pro Asn

(2S)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C17H29N5O6S (431.18384540000005)


   

Gly Met Pro Gln

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C17H29N5O6S (431.18384540000005)


   

Gly Met Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6S (431.18384540000005)


   

Gly Asn Asn Gln

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-carbamoylpropanamido]-4-carbamoylbutanoic acid

C15H25N7O8 (431.176453)


   

Gly Asn Gln Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-4-carbamoylbutanamido]-3-carbamoylpropanoic acid

C15H25N7O8 (431.176453)


   

Gly Pro Met Gln

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanamido]-4-carbamoylbutanoic acid

C17H29N5O6S (431.18384540000005)


   

Gly Pro Gln Met

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]-4-(methylsulfanyl)butanoic acid

C17H29N5O6S (431.18384540000005)


   

Gly Gln Met Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6S (431.18384540000005)


   

Gly Gln Asn Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-carbamoylpropanamido]-3-carbamoylpropanoic acid

C15H25N7O8 (431.176453)


   

Gly Gln Pro Met

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanoic acid

C17H29N5O6S (431.18384540000005)


   

Met Ala Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]propanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6S (431.18384540000005)


   

Met Ala Pro Asn

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]propanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C17H29N5O6S (431.18384540000005)


   

Met Gly Pro Gln

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetyl}pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C17H29N5O6S (431.18384540000005)


   

Met Gly Gln Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6S (431.18384540000005)


   

Met Asn Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]propanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6S (431.18384540000005)


   

Met Asn Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C17H29N5O6S (431.18384540000005)


   

Met Pro Ala Asn

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}propanamido]-3-carbamoylpropanoic acid

C17H29N5O6S (431.18384540000005)


   

Met Pro Gly Gln

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}acetamido)-4-carbamoylbutanoic acid

C17H29N5O6S (431.18384540000005)


   

Met Pro Asn Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]propanoic acid

C17H29N5O6S (431.18384540000005)


   

Met Pro Gln Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]acetic acid

C17H29N5O6S (431.18384540000005)


   

Met Gln Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-carbamoylbutanamido]acetyl}pyrrolidine-2-carboxylic acid

C17H29N5O6S (431.18384540000005)


   

Met Gln Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}acetic acid

C17H29N5O6S (431.18384540000005)


   

Asn Ala Met Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6S (431.18384540000005)


   

Asn Ala Asn Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-carbamoylpropanamido]-3-carbamoylpropanoic acid

C15H25N7O8 (431.176453)


   

Asn Ala Pro Met

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanoic acid

C17H29N5O6S (431.18384540000005)


   

Asn Cys Pro Val

(2S)-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C17H29N5O6S (431.18384540000005)


   

Asn Cys Val Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6S (431.18384540000005)


   

Asn Gly Asn Gln

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-carbamoylpropanamido]-4-carbamoylbutanoic acid

C15H25N7O8 (431.176453)


   

Asn Gly Gln Asn

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-4-carbamoylbutanamido]-3-carbamoylpropanoic acid

C15H25N7O8 (431.176453)


   

Asn Met Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-(methylsulfanyl)butanamido]propanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6S (431.18384540000005)


   

Asn Met Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C17H29N5O6S (431.18384540000005)


   

Asn Asn Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carbamoylpropanamido]propanamido]-3-carbamoylpropanoic acid

C15H25N7O8 (431.176453)


   

Asn Asn Gly Gln

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carbamoylpropanamido]acetamido}-4-carbamoylbutanoic acid

C15H25N7O8 (431.176453)


   

Asn Asn Asn Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]propanoic acid

C15H25N7O8 (431.176453)


   

Asn Asn Gln Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carbamoylpropanamido]-4-carbamoylbutanamido]acetic acid

C15H25N7O8 (431.176453)


   

Asn Pro Ala Met

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}propanamido]-4-(methylsulfanyl)butanoic acid

C17H29N5O6S (431.18384540000005)


   

Asn Pro Cys Val

(2S)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-methylbutanoic acid

C17H29N5O6S (431.18384540000005)


   

Asn Pro Met Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanamido]propanoic acid

C17H29N5O6S (431.18384540000005)


   

Asn Pro Val Cys

(2R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-sulfanylpropanoic acid

C17H29N5O6S (431.18384540000005)


   

Asn Gln Gly Asn

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carbamoylbutanamido]acetamido}-3-carbamoylpropanoic acid

C15H25N7O8 (431.176453)


   

Asn Gln Asn Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carbamoylbutanamido]-3-carbamoylpropanamido]acetic acid

C15H25N7O8 (431.176453)


   

Asn Val Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylbutanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6S (431.18384540000005)


   

Asn Val Pro Cys

(2R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C17H29N5O6S (431.18384540000005)


   

Pro Ala Met Asn

(2S)-3-carbamoyl-2-[(2S)-4-(methylsulfanyl)-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]propanoic acid

C17H29N5O6S (431.18384540000005)


   

Pro Ala Asn Met

(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]-4-(methylsulfanyl)butanoic acid

C17H29N5O6S (431.18384540000005)


   

Pro Cys Asn Val

(2S)-2-[(2S)-3-carbamoyl-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]propanamido]-3-methylbutanoic acid

C17H29N5O6S (431.18384540000005)


   

Pro Cys Val Asn

(2S)-3-carbamoyl-2-[(2S)-3-methyl-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]butanamido]propanoic acid

C17H29N5O6S (431.18384540000005)


   

Pro Gly Met Gln

(2S)-4-carbamoyl-2-[(2S)-4-(methylsulfanyl)-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanamido]butanoic acid

C17H29N5O6S (431.18384540000005)


   

Pro Gly Gln Met

(2S)-2-[(2S)-4-carbamoyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanamido]-4-(methylsulfanyl)butanoic acid

C17H29N5O6S (431.18384540000005)


   
   

Pro Met Ala Asn

(2S)-3-carbamoyl-2-[(2S)-2-[(2S)-4-(methylsulfanyl)-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]propanoic acid

C17H29N5O6S (431.18384540000005)


   

Pro Met Gly Gln

(2S)-4-carbamoyl-2-{2-[(2S)-4-(methylsulfanyl)-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]acetamido}butanoic acid

C17H29N5O6S (431.18384540000005)


   

Pro Met Asn Ala

(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-4-(methylsulfanyl)-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]propanoic acid

C17H29N5O6S (431.18384540000005)


   

Pro Met Gln Gly

2-[(2S)-4-carbamoyl-2-[(2S)-4-(methylsulfanyl)-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanamido]acetic acid

C17H29N5O6S (431.18384540000005)


   

Pro Asn Ala Met

(2S)-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]-4-(methylsulfanyl)butanoic acid

C17H29N5O6S (431.18384540000005)


   

Pro Asn Cys Val

(2S)-2-[(2R)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-sulfanylpropanamido]-3-methylbutanoic acid

C17H29N5O6S (431.18384540000005)


   

Pro Asn Met Ala

(2S)-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-4-(methylsulfanyl)butanamido]propanoic acid

C17H29N5O6S (431.18384540000005)


   

Pro Asn Val Cys

(2R)-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-methylbutanamido]-3-sulfanylpropanoic acid

C17H29N5O6S (431.18384540000005)


   

Pro Gln Gly Met

(2S)-2-{2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]acetamido}-4-(methylsulfanyl)butanoic acid

C17H29N5O6S (431.18384540000005)


   

Pro Gln Met Gly

2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-4-(methylsulfanyl)butanamido]acetic acid

C17H29N5O6S (431.18384540000005)


   

Pro Val Cys Asn

(2S)-3-carbamoyl-2-[(2R)-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-sulfanylpropanamido]propanoic acid

C17H29N5O6S (431.18384540000005)


   

Pro Val Asn Cys

(2R)-2-[(2S)-3-carbamoyl-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]-3-sulfanylpropanoic acid

C17H29N5O6S (431.18384540000005)


   

Gln Gly Met Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6S (431.18384540000005)


   

Gln Gly Asn Asn

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-carbamoylpropanamido]-3-carbamoylpropanoic acid

C15H25N7O8 (431.176453)


   

Gln Gly Pro Met

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetyl}pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanoic acid

C17H29N5O6S (431.18384540000005)


   

Gln Met Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-(methylsulfanyl)butanamido]acetyl}pyrrolidine-2-carboxylic acid

C17H29N5O6S (431.18384540000005)


   

Gln Met Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}acetic acid

C17H29N5O6S (431.18384540000005)


   

Gln Asn Gly Asn

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carbamoylpropanamido]acetamido}-3-carbamoylpropanoic acid

C15H25N7O8 (431.176453)


   

Gln Asn Asn Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]acetic acid

C15H25N7O8 (431.176453)


   

Gln Pro Gly Met

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}acetamido)-4-(methylsulfanyl)butanoic acid

C17H29N5O6S (431.18384540000005)


   

Gln Pro Met Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanamido]acetic acid

C17H29N5O6S (431.18384540000005)


   

Val Cys Asn Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-methylbutanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6S (431.18384540000005)


   

Val Cys Pro Asn

(2S)-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-3-methylbutanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C17H29N5O6S (431.18384540000005)


   

Val Asn Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6S (431.18384540000005)


   

Val Asn Pro Cys

(2R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C17H29N5O6S (431.18384540000005)


   

Val Pro Cys Asn

(2S)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C17H29N5O6S (431.18384540000005)


   

Val Pro Asn Cys

(2R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C17H29N5O6S (431.18384540000005)


   

L-Octahydroindole-2-carboxylic acid benzyl ester 4-methylbenzenesulfonate

L-Octahydroindole-2-carboxylic acid benzyl ester 4-methylbenzenesulfonate

C23H29NO5S (431.17663440000007)


   

Ethaverine hydrochloride

Isoquinoline,1-[(3,4-diethoxyphenyl)methyl]-6,7-diethoxy-, hydrochloride (1:1)

C24H30ClNO4 (431.18632500000007)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor C93038 - Cation Channel Blocker

   

5-(N,N-Dibenzylglycyl)-2-hydroxybenzamide

5-(N,N-Dibenzylglycyl)-2-hydroxybenzamide

C25H25N3O4 (431.184497)


   

Succinimidyl (2R)-6-(Tetrahydro-2H-pyran-2-yloxy)-2,5,7,8-tetramethylchroman-2-carboxylate

Succinimidyl (2R)-6-(Tetrahydro-2H-pyran-2-yloxy)-2,5,7,8-tetramethylchroman-2-carboxylate

C23H29NO7 (431.1943924)


   

2-Methyl-3-[4-(3-pyrrolidin-1-ylpropoxy)phenyl]-5-(trifluoromethyl)quinazolin-4-one

2-Methyl-3-[4-(3-pyrrolidin-1-ylpropoxy)phenyl]-5-(trifluoromethyl)quinazolin-4-one

C23H24F3N3O2 (431.182052)


   

Esreboxetine succinate

Esreboxetine succinate

C23H29NO7 (431.1943924)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C185721 - Norepinephrine Reuptake Inhibitor C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

Diphenhydramine N-glucuronide

Diphenhydramine N-glucuronide

C23H29NO7 (431.1943924)


   
   

(5Z)-4-methoxy-3-methyl-5-[(1R,6S,8R,9R,10R,11S)-11-methyl-6-[(2S,4S)-4-methyl-5-oxooxolan-2-yl]-13,14-dioxa-5-azatetracyclo[6.5.1.01,10.05,9]tetradecan-12-ylidene]furan-2-one

(5Z)-4-methoxy-3-methyl-5-[(1R,6S,8R,9R,10R,11S)-11-methyl-6-[(2S,4S)-4-methyl-5-oxooxolan-2-yl]-13,14-dioxa-5-azatetracyclo[6.5.1.01,10.05,9]tetradecan-12-ylidene]furan-2-one

C23H29NO7 (431.1943924)


   

1-Methyl-6-[(4-methyl-1-piperidinyl)sulfonyl]-3-[oxo(1-piperidinyl)methyl]-4-quinolinone

1-Methyl-6-[(4-methyl-1-piperidinyl)sulfonyl]-3-[oxo(1-piperidinyl)methyl]-4-quinolinone

C22H29N3O4S (431.1878674000001)


   

1-methyl-N-(2-methylcyclohexyl)-4-oxo-6-(1-pyrrolidinylsulfonyl)-3-quinolinecarboxamide

1-methyl-N-(2-methylcyclohexyl)-4-oxo-6-(1-pyrrolidinylsulfonyl)-3-quinolinecarboxamide

C22H29N3O4S (431.1878674000001)


   

N-[4-(diethylsulfamoyl)phenyl]-4-(4-morpholinylmethyl)benzamide

N-[4-(diethylsulfamoyl)phenyl]-4-(4-morpholinylmethyl)benzamide

C22H29N3O4S (431.1878674000001)


   
   
   

(2R,3R,3aS,9bS)-3-(hydroxymethyl)-6-oxo-7-phenyl-1-(2-pyridinylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester

(2R,3R,3aS,9bS)-3-(hydroxymethyl)-6-oxo-7-phenyl-1-(2-pyridinylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester

C25H25N3O4 (431.184497)


   

(2S,3S,3aR,9bR)-3-(hydroxymethyl)-6-oxo-7-phenyl-1-(2-pyridinylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester

(2S,3S,3aR,9bR)-3-(hydroxymethyl)-6-oxo-7-phenyl-1-(2-pyridinylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester

C25H25N3O4 (431.184497)


   
   
   
   
   

3beta-Chloro-N,N-bis(2-chloroethyl)-androst-5-en-17beta-amine

3beta-Chloro-N,N-bis(2-chloroethyl)-androst-5-en-17beta-amine

C23H36Cl3N (431.19131860000005)


   

Fusarin C

Fusarin C

C23H29NO7 (431.1943924)


D009676 - Noxae > D009153 - Mutagens

   
   
   

SOS1-IN-11

SOS1-IN-11

C22H24F3N5O (431.193285)


SOS1-IN-11 is a potent SOS1 inhibitor with an IC50 value of 30 nM.